Neudle.com: anticonvulsants untoward effects of

Differential
(Click to cross reference)

abducens nerve paralysis

abortion, spontaneous

acetazolamide

acquired immunodeficiency syndrome dementia complex

acute intermittant porphyria

advances in neurology

adverse drug reaction

amyloid angiopathy, cerebral

anemia, megaloblastic

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticoagulant, complications of

anticonvulsants

anticonvulsants, bioavailability

anticonvulsants, blood level determination of

anticonvulsants, brand name

anticonvulsants, cognitive function with

anticonvulsants, compliance

anticonvulsants, discontinuation

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, enzyme inducing

anticonvulsants, generic

anticonvulsants, hypersensitivity syndrome

anticonvulsants, loading dose

anticonvulsants, mechanism of action of

anticonvulsants, parenteral administration

anticonvulsants, pharmacokinetics

anticonvulsants, rate of administration

anticonvulsants, rectal administration

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

atrioventricular block

attention deficit disorder with hyperactivity

basal ganglia, lesion, bilateral

bee sting

bee sting, neurologic complications with

behavior

behavioral disorder

benign essential tremor

benzodiazepine

beta adrenergic blocker

black box warning

blood dyscrasias, neurologic findings with

bone density

bone loss

bone marrow suppression

brainstem, infarction of

brand name drug

breast feeding

burst suppression pattern, electroencephalogram

caffeine

calcium

calcium antagonist

calcium antagonist, side effects of

carbamazepine, controlled release

carbamazepine, toxicity

cardiac tumor

carnitine deficiency

CAT scan

cauda equina, lesion of

central nervous system, infection of

cerebellar degeneration

cerebral cortical atrophy

cerebrospinal fluid, elevated protein of

cerebrovascular accident

cerebrovascular accident, complications with

cerebrovascular accident, infancy and childhood

cerebrovascular accident, seizure with

cerebrovascular disease

chemosis

chemotherapy, CNS treatment and complications with

chest x-ray, abnormal

Clinical Pathologic Conference(C.P.C.)

collagen vascular disease

color vision

color vision, impaired

congenital birth defects

congenital deformities

congenital heart disease

congenital heart disease, CNS complications with

congenital malformation

congenital malformation, dilantin therapy causing

congenital malformation, non CNS

congestive heart failure

conjunctival injection

conjunctivitis

contrast agents, neurotoxicity of

controversies in neurology

copper deficiency

corpus callosum

corpus callosum, lesion of

cranial neuropathy, multiple

Craniosynostosis

creatine phosphokinase(CPK)elevated

developmental disability

developmental evaluation

developmental milestones

developmental retardation

diabetes insipidus

diazepam rectal gel

differential diagnosis

digits, abnormal

dilantin

dilantin, factors influencing metabolism of

dilantin, hypersensitivity to

dilantin, intravenous

dilantin, serum level

dilantin, toxicity

diltiazem

diplopia

disseminated intravascular coagulation(DIC)

drug induced neurologic disorders

drug induced neurologic disorders in children

Dupuytren's contractures

dysarthria

dysgeusia

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dystonia, drug induced

dystonic reaction, acute

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroretinograph

embryogenesis

encephalitis

encephalitis, human immunodeficiency virus type 1

epidemiology of neurology

epilepsy

epilepsy referral centers

eye movement, disorders of

fetal valproate syndrome

fetus

fever

fine motor function, impaired

fingernails, abnormal

fingernails, hypoplastic

fluorescent treponema antibody absorption/false positive

fluoroquinolones

folic acid

folic acid antagonists

folic acid deficiency

fosphenytoin

fracture, long bone

fracture, pathologic

fundus, abnormality of

gabapentin

gait, waddling

gamma amino butyric acid

gamma amino butyric acid-mimetic drug

genetic neurologic disorders

Gilles de la Tourette syndrome

Guillain Barre syndrome

gynecomastia

hallucination

hallucination, visual

head circumference

head injury

head injury, management of

headache

headache, progressive

hemophagocytic lymphohistiocytosis

hemorrhagic diathesis

hepatic encephalopathy

heralding manifestation

hospital length of stay

hospitalization

human immunodeficiency virus type 1

hyperactivity

hyperammonemic encephalopathy

hypersensitivity reaction

hypertelorism

hypocalcemia

hypogammaglobulinemia

hyponatremia

hypospadias

hypotension, systemic

hypothalamus, disturbance of

hypothermia

iatrogenic neurologic disorders

imbalance

immunization, neurologic complications with

intellectual deterioration

intelligence quotient

intelligence testing in children

interferon

intracerebral hemorrhage

intracranial hypertension, benign

intracranial hypertension, benign, children

intracranial pressure, increased

intraocular pressure, increase

intrauterine

irritability

isoniazid

Jakob-Creutzfeldt disease

jaundice

juvenile myoclonus epilepsy

lamotrigine

learning disability

Ledderhose disease

Lennox-Gastaut syndrome

leukemia

leukocytosis

leukopenia

level of consciousness, decreased

liver function enzymes

liver transplantation

malabsorption syndrome

malformation, CNS, congenital

manic-depressive

meningitis

meningitis, aseptic

meningitis, bacterial-negative CSF culture

meningitis, drug induced

meningitis, noninfectious

menses, irregular

menses, seizure with

mental retardation

mental status, abnormal

mesial temporal sclerosis

midline defect in children

migraine

migraine, treatment of

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

MRI

MRI, abnormal

MRI, abnormal, seizure causing

MRI, disappearing lesion on

MRI, functional

MRI, negative

MRI, vessel wall

MRI, vessel wall enhancement

multiple sclerosis

multiple system atrophy

muscle pain

muscle tenderness

muscle weakness

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, drug induced

myasthenia gravis, unmasked

myasthenic syndrome

myelitis

myelopathy

myelopathy, chronic progressive

myopathy, drug-induced

myopia

myopia, sudden onset of

myositis

myotonia dystrophica

myotonia, treatment of

neoplasm, intracranial

neoplasm, primary of CNS

nerve biopsy

nerve conduction studies

neural crest, tumor

neural tube defect

neuralgia, treatment of

neurologic complications of, systemic disease

neurologic consultation

neurologic disease

neurologic examination, focal

neuromuscular blockade

neuromuscular junction, abnormality of

neuropathy

neuropathy, peripheral

nutritional deficiency

nystagmus

nystagmus, periodic alternating

nystagmus, primary position of gaze

obesity

obicularis oculi, weakness of

obstetric neurologic injuries

ocular motility, disorders of

oculocephalic reflex

oculovestibular reflex

old age, neurology of

ophthalmoplegia

ophthalmoplegia, total

optic neuritis

optokinetic nystagmus(O.K.N.)

oral contraceptives

oral contraceptives, neurologic complications with

organ transplantation

orgasm

ornithine transcarbamylase deficiency

pain, management of chronic

paresthesias, generalized

Parkinson disease

Parkinson disease, drug induced

Parkinsonism syndrome

patient information and support

phencyclidine poisoning

poison, neurologic problems with

polycystic ovarian syndrome

posterior inferior cerebellar artery syndrome

postoperative neurologic complications

postpartum

practice guidelines

precipitating factors

pregabalin

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

premarin

prenatal

prenatal diagnosis by amniocentesis

prevention of neurologic disorders

procainamide

progesterone

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

propofol

propranolol

protein 14-3-3, cerebrospinal fluid

protein 14-3-3, cerebrospinal fluid, false positive

protein C deficiency

pseudolymphoma

psychiatric disorder

psychiatric problems in neurologic disorders

psychological testing

psychological testing, children

psychomotor retardation

pulmonary function tests

pulmonary infiltrates

pupil, abnormality in neurologic disorders

pupil, dilated and fixed, bilateral

pupil, dilated, bilateral

Purkinje cell

purple glove syndrome

radiation therapy, CNS treatment and complications with

rash

reaction time

red cell aplasia

reflex sympathetic dystrophy

respiratory depression

respiratory failure

respiratory paralysis, pharmacologic

restless leg syndrome

retinal lesion

retinopathy

reversible cerebral vasoconstrictive syndromes

review article

rhabdomyolysis

rheumatoid arthritis, neurologic complications of

rickets

risk factors

risk-benefit assessment

safety

salivation, excessive

sedation

seizure

seizure, adult onset

seizure, age of onset

seizure, children

seizure, classification of

seizure, complications following

seizure, diagnosis of

seizure, differential diagnosis of

seizure, drug resistance

seizure, drug-induced

seizure, intractable, treatment of

seizure, nonconvulsive

seizure, non-treatment of

seizure, paradoxical

seizure, petit mal

seizure, post traumatic

seizure, pregnancy

seizure, prevention of

seizure, prognosis in adults

seizure, prognosis in childhood

seizure, psychomotor-temporal lobe

seizure, psychosocial aspects of

seizure, surgical treatment of

seizure, systemic disease causing

seizure, teenager

seizure, tonic-clonic

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, treatment of, polytherapy

seizure, withdrawal

seizure, women

seizure, workup of

sensorineural hearing loss

sensory loss

serum glutamic oxaloacetic transaminase

serum sickness

sexual behavior, disorder of

sexual dysfunction in neurologic disease

shoulder, frozen

shoulder-hand syndrome

single photon emission computed tomography

sinus arrest

skin, biopsy

skin, lesions in neurologic disorders

sodium valproate

sodium valproate, intravenous

sodium valproate, toxicity

somatosensory evoked potentials

spinal cord, injury of

spinal cord, injury, sexual dysfunction in

spinal cord, lesion of

splenium of corpus callosum

splenomegaly

status epilepticus

status epilepticus, nonconvulsive

steroid

steroid therapy, CNS treatment and complications with

Stevens-Johnson syndrome

stillbirth

stuporous

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

suicide

superior cerebellar artery infarction

sympathomimetic drugs

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, drug induced

systemic lupus erythematosus, neurologic complications with

testosterone, serum, elevated

tetanus antitoxin

thermoregulatory disorder

thrombocytopenia

thyroid function tests

tiagabine

timolol

topiramate

toxic epidermal necrolysis

tranquilizers, neurologic complications with

transient epileptic amnesia

transient neurologic deficit

trauma

treatment of neurologic disorder

tremor

tremor, treatment of

trigeminal neuralgia

trigeminal neuralgia, treatment of

trigeminal neuropathy

trimethadione

trimethoprim-sulfamethoxazole

tuberous sclerosis

ultrasonography

ultrasonography, head, fetus-neonate

urea-cycle enzymopathies

uremia

urinary incontinence

urticaria

vagus nerve stimulation

visual acuity, decreased

visual evoked response

visual field defect

visual fields

visual fields, constricted

vitamin supplementation

vitamin therapy

vitamin, multiple

weakness

weakness, generalized

weaning from respirator, failure to

Showing articles 400 to 450 of 5722 << Previous Next >>

Tocilizumab Treatment for New Onset Refractory Status Epilepticus
Ann Neurol 84:940-945, Jun, J.,et al, 2018

Cannabidiol in Patients with Seizures Associated with Lennox-Gastaut Syndrome (GWPCARE4): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial
Lancet 391:1085-1096, Thiele, E.A.,et al, 2018

Neonatal Abstinence Syndrome
JAMA 319:1362-1374, Wachman, E.,et al, 2018

Cranial Cavernous Malformations
Stroke 49:1029-1035, Stapleton, C.J. & Barker, F.G., 2018

Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
NEJM 378:1888-1897, Devinsky, O.,et al, 2018

Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation
Psychiatry.com 2018, Papp, A. & Onton, J.A., 2018

Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis
AJNR 38:1070-1078, Kelley, B.P.,et al, 2017

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
NEJM 376:2011-2020, Devinsky, O.,et al, 2017

Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis
AJNR 38:1070-1078, Kelley, B.P.,et al, 2017

Migraine
NEJM 377:553-561, Charles, A., 2017

Rebound Syndrome in Patients with Multiple Sclerosis after Cessation of Fingolimod Treatment
JAMA Neurol 73:790-794, Hatcher, S.E.,et al, 2016

Neonatal Abstinence Syndrome
NEJM 375:2468-2479, McQueen, K. & Murphy-Oikonen, J., 2016

Long-Term Treatment of Epilepsy with Everolimus in Tuberous Sclerosis
Neurol 87:2408-2415, Krueger, D.A.,et al, 2016

A 62-Year-Old Woman with Bizarre Behavior and Recurrent Episodes of Behavioral Arrest
Neurol 86:e62-e65, Briglia, H.,et al, 2016

Myasthenia Gravis Exacerbation after Discontinuing Mycophenolate
Neurol 86:1159-1163, Oskarsson, B.,et al, 2016

Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Current Status, Special Situations, and Unmet Needs
Lancet 386:303-310, Verheugt, F.W.A. & Granger, C.B., 2015

Varicella-Zoster Virus Infections in Patients Treated with Fingolimod
JAMA Neurol 72:31-39,10, Arvin, A.M.,et al, 2015

Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy
JAMA 313:285-293, Jobst, B.C. & Cascino, G.D., 2015

Treatment of Brain Metastases
J Clin Oncol 33:3475-3484, Lin, X. & DeAngelis, L.M., 2015

Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab
JAMA Neurol 71:954-960, Clerico, M.,et al, 2014

Utility of an Immunotherapy Trial in Evaluating Patients with Presumed Autoimmune Epilepsy
Neurol 82:1578-1586, Toledano, M.,et al, 2014

Antiepileptic Drugs for Neuropathic Pain and Fibromyalgia
JAMA 312:182-183, Moore, A.,et al, 2014

Histoplasmosis in Patient with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS)
Medicine 93:11-18, Myint, T.,et al, 2014

Withdrawing Amantadine in Dyskinetic Patients with Parkinson Disease
Neurol 82:300-307, Ory-Magne, F.,et al, 2014

Serotonin Syndrome
BMJ 348:g1626, Buckley, N.A.,et al, 2014

Anesthetic Drugs in Status Epilepticus: Risk or Rescue?
Neurol 82:656-664, Sutter, R.,et al, 2014

Triptans for Symptomatic Treatment of Migraine Headache
BMJ 348:g2285, Pringsheim, T. & Becker, W.J., 2014

Progressive Multifocal Leukoencephalopathy in Patients with Sarcoidosis
Neurol 82:1307-1313, Jamilloux, Y.,et al, 2014

Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Monoamine Oxidase Inhibitors
Adams & Victors Principles of Neurology Chp 43, pg 1210, Ropper, A.H.,et al, 2014

Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Tricyclic Antidepressants
Adams & Victors Principles of Neurology Chp 43, pg 1211, Ropper, A.H.,et al, 2014

Sturge-Weber Syndrome
UptoDate , Nov, Bodensteiner, J.B., 2014

Should Statins be Paused or Discontinued After Thrombolysis or Acute Intracerebral Hemorrhage? No!
Stroke 44:1472-1476, Scheitz, J.F.,et al, 2013

Serotonin Syndrome Associated with Clozapine Withdrawal
JAMA Neurol 70:1054-1055, Stevenson, E.,et al, 2013

Statin Therapy should not be Discontinued in Patients with Intracerebral Hemorrhage
Stroke 44:2060-2061,2062, Bustamante, A. & Montaner, J., 2013

Statin Therapy should be Discontinued in Patients with Intracerebral Hemorrhage
Stroke 44:2058-2059,2062, Goldstein, L., 2013

Clinical Features of Dopamine Agonist Withdrawal Syndrome in a Movement Disorders Clinic
JNNP 84:130-135, Pondal, M.,et al, 2013

Randomized Controlled Trial of Trigeminal Nerve Stimulation for Drug-Resistant Epilepsy
Neurol 80:786-791,780, DeGiorgio, C.,et al, 2013

Evidence-Based Guideline Update: Vagus Nerve Stimulation for the Treatment of Epilepsy
Neurol 81:1453-1459, Morries, G.L.,et al, 2013

Sturge-Weber Syndrome
MedLink Neurology, July, Comi, A.M., 2013

Everolimus Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Ann Neurol 74:679-687, Krueger, D.A.,et al, 2013

Statin Use During Ischemic Stroke Hospitalization is Strongly Associated with Improved Poststroke Survival
Stroke 43:147-154, Flint, A.C.,et al, 2012

Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy
JAMA 307:922-930,966,985, Engel,J.,et al, 2012

Acute Symptomatic Seizures
The Neurologist 18:109-119, Beleza,P., 2012

Autoimmune Epilepsy
Arch Neurol 69:582-593,565, Quek, A.M.L.,et al, 2012

Adverse Effect of Early Epileptic Seizures in Patients Receiving Endovascular Therapy for Acute Stroke
Stroke 43:1584-1590, Jung, S.,et al, 2012

Using Dabigatran in Patients with Stroke A Practical Guide for Clinicians
Stroke 43:271-279, Alberts, M.J.,et al, 2012

Intramuscular Versus Intravenous Therapy for Prehospital Status Epilepticus
NEJM 366:591-600,659, Silbergleit,R.,et al, 2012

Relapse Risk after Discontinuation of Risperidone in Alzheimers Disease
NEJM 367:1497-1507, Devanand, D.P.,et al, 2012

Results of Phase 2 Safety and Feasibility Study of Treatment with Levetiracetam for Prevention of Posttraumatic Epilepsy
Arch Neurol 69:1290-1295, Klein, P.,et al, 2012

Severe Relapses under Fingolimod Treatment Prescribed after Natalizumab
Neurol 79:2004-2006,1942, Centonze, D.,et al, 2012

Showing articles 400 to 450 of 5722 << Previous Next >>